$BCRX
BIOCRYST PHARMACEUTICALS INC

2019 Q1 Form 10-Q Financial Statement

#000117184319003220 Filed on May 09, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $5.887M $3.976M
YoY Change 48.06% -57.87%
Cost Of Revenue $1.399M
YoY Change
Gross Profit $4.488M $3.976M
YoY Change 12.88% -56.5%
Gross Profit Margin 76.24% 100.0%
Selling, General & Admin $6.238M $7.609M
YoY Change -18.02% 148.82%
% of Gross Profit 138.99% 191.37%
Research & Development $27.49M $18.44M
YoY Change 49.09% 9.96%
% of Gross Profit 612.59% 463.81%
Depreciation & Amortization $176.0K $186.0K
YoY Change -5.38% 8.14%
% of Gross Profit 3.92% 4.68%
Operating Expenses $33.73M $26.05M
YoY Change 29.49% 31.38%
Operating Profit -$29.33M -$22.21M
YoY Change 32.03% 107.9%
Interest Expense $2.726M $2.221M
YoY Change 22.74% 5.76%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$31.05M -$25.78M
YoY Change 20.44% 81.29%
Income Tax
% Of Pretax Income
Net Earnings -$31.05M -$25.78M
YoY Change 20.47% 81.29%
Net Earnings / Revenue -527.5% -648.31%
Basic Earnings Per Share
Diluted Earnings Per Share -$281.8K -$261.5K
COMMON SHARES
Basic Shares Outstanding 110.2M
Diluted Shares Outstanding 110.2M 98.59M

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.6M $91.31M
YoY Change 17.8% -7.47%
Cash & Equivalents $34.80M $43.77M
Short-Term Investments $72.75M $47.54M
Other Short-Term Assets $4.500M $7.200M
YoY Change -37.5% 56.52%
Inventory $600.0K $7.000K
Prepaid Expenses
Receivables $5.002M $5.694M
Other Receivables $0.00 $0.00
Total Short-Term Assets $117.6M $104.2M
YoY Change 12.95% -8.23%
LONG-TERM ASSETS
Property, Plant & Equipment $7.644M $9.395M
YoY Change -18.64% -3.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $11.70M $41.60M
YoY Change -71.88% 994.74%
Other Assets $5.390M $222.0K
YoY Change 2327.93% -90.22%
Total Long-Term Assets $24.69M $51.22M
YoY Change -51.79% 219.88%
TOTAL ASSETS
Total Short-Term Assets $117.6M $104.2M
Total Long-Term Assets $24.69M $51.22M
Total Assets $142.3M $155.4M
YoY Change -8.39% 19.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.935M $3.588M
YoY Change 93.28% -33.96%
Accrued Expenses $16.55M $15.62M
YoY Change 5.91% 37.84%
Deferred Revenue
YoY Change
Short-Term Debt $29.20M $28.80M
YoY Change 1.39% 1.41%
Long-Term Debt Due $0.00 $6.600M
YoY Change -100.0% 407.69%
Total Short-Term Liabilities $66.33M $75.34M
YoY Change -11.97% 28.66%
LONG-TERM LIABILITIES
Long-Term Debt $49.60M $17.80M
YoY Change 178.65% -26.75%
Other Long-Term Liabilities $3.889M $100.0K
YoY Change 3789.0% -98.77%
Total Long-Term Liabilities $3.889M $17.90M
YoY Change -78.27% -44.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $66.33M $75.34M
Total Long-Term Liabilities $3.889M $17.90M
Total Liabilities $70.22M $93.30M
YoY Change -24.74% 2.53%
SHAREHOLDERS EQUITY
Retained Earnings -$762.8M -$630.7M
YoY Change 20.94% 8.69%
Common Stock $1.103M $987.0K
YoY Change 11.75% 22.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.51M $62.05M
YoY Change
Total Liabilities & Shareholders Equity $142.3M $155.4M
YoY Change -8.39% 19.97%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$31.05M -$25.78M
YoY Change 20.47% 81.29%
Depreciation, Depletion And Amortization $176.0K $186.0K
YoY Change -5.38% 8.14%
Cash From Operating Activities -$27.00M -$19.65M
YoY Change 37.37% 130.48%
INVESTING ACTIVITIES
Capital Expenditures -$90.00K -$40.00K
YoY Change 125.0%
Acquisitions
YoY Change
Other Investing Activities $15.97M $15.96M
YoY Change 0.06% 23.91%
Cash From Investing Activities $15.88M $15.93M
YoY Change -0.29% 12.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.04M -1.476M
YoY Change -1457.72% -103.03%
NET CHANGE
Cash From Operating Activities -27.00M -19.65M
Cash From Investing Activities 15.88M 15.93M
Cash From Financing Activities 20.04M -1.476M
Net Change In Cash 8.923M -5.202M
YoY Change -271.53% -109.58%
FREE CASH FLOW
Cash From Operating Activities -$27.00M -$19.65M
Capital Expenditures -$90.00K -$40.00K
Free Cash Flow -$26.91M -$19.61M
YoY Change 37.19% 130.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
-62000
CY2018Q1 bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
76000
CY2019Q1 bcrx Available For Sale Debt Securities Accrued Interest
AvailableForSaleDebtSecuritiesAccruedInterest
421000
CY2018Q4 bcrx Available For Sale Debt Securities Accrued Interest
AvailableForSaleDebtSecuritiesAccruedInterest
444000
CY2019Q1 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
11655000
CY2018Q4 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
22376000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6935000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7769000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5002000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4293000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16547000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15938000
CY2019Q1 bcrx Increase Decrease In Financing Lease Obligations
IncreaseDecreaseInFinancingLeaseObligations
CY2018Q1 bcrx Increase Decrease In Financing Lease Obligations
IncreaseDecreaseInFinancingLeaseObligations
-19000
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
77736000
CY2019Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
84408000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
19000
CY2019Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
141000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
316000
CY2019Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
84076000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
99965000
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
72753000
CY2019Q1 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized For Remainder Of Fiscal Year
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedForRemainderOfFiscalYear
8033000
CY2019Q1 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Five
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearFive
69000
CY2019Q1 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Four
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearFour
4849000
CY2019Q1 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Three
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearThree
6333000
CY2019Q1 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Two
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearTwo
8310000
CY2017Q4 bcrx Maximum Aggregate Offering Price
MaximumAggregateOfferingPrice
200000000
CY2019Q1 bcrx Number Of Stockbased Compensation Plans
NumberOfStockbasedCompensationPlans
2
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-89000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-297000
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
784278000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
780400000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3317000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2903000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3317000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2903000
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
255000
CY2018Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
232000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3406000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1775000
CY2019Q1 us-gaap Assets
Assets
142338000
CY2018Q4 us-gaap Assets
Assets
146841000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
117649000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
114352000
CY2019Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
52000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
100112000
CY2019Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
72753000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
77736000
CY2019Q1 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
11655000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
22376000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34804000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26731000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
35217000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
26190000
CY2018Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
238000
CY2017Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
1126000
CY2019Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
9000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28275000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53568000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37198000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48366000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8923000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5202000
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110270000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110063000
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
110270000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
110063000
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
1103000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1101000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30846000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26010000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1399000
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
CY2018Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
9000
CY2019Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
54000
CY2019Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
221000
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
221000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
176000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
186000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
27594000
CY2019Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
406000
CY2018Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-1804000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1429000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
152000
CY2019Q1 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
406000
CY2018Q1 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-1804000
CY2019Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1544000
CY2018Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1370000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1049000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-321000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1015000
CY2019Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
709000
CY2018Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-423000
CY2019Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
596000
CY2018Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
462000
CY2019Q1 us-gaap Interest Expense
InterestExpense
2726000
CY2018Q1 us-gaap Interest Expense
InterestExpense
2221000
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
2725000
CY2018Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
2136000
CY2019Q1 us-gaap Interest Payable Current
InterestPayableCurrent
13392000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
11848000
CY2019Q1 us-gaap Inventory Net
InventoryNet
600000
CY2018Q4 us-gaap Inventory Net
InventoryNet
1649000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11722000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
7766000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
512000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
505000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
543000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1300000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1096000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6513000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
142338000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
146841000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
66326000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
69477000
CY2019Q1 us-gaap Line Of Credit
LineOfCredit
49616000
CY2018Q4 us-gaap Line Of Credit
LineOfCredit
25372000
CY2019Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4580000
CY2019Q1 us-gaap Long Term Debt
LongTermDebt
50000000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
20000000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20000000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
10000000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20040000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5209000
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.126
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5390000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
978000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
208000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-233000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
208000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1476000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15881000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15927000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26998000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19653000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-31054000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-25777000
CY2019Q1 us-gaap Notes Payable Current
NotesPayableCurrent
29231000
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
29121000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-29330000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-22214000
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
309000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-233000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3889000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2703000
CY2019Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3018000
CY2018Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
4327000
CY2019Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
93000
CY2018Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
35000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2087000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2390000
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53400000
CY2019Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
19477000
CY2018Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
18992000
CY2018Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
20289000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
563000
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
268000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7644000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9135000
CY2019Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
5002000
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4293000
CY2019Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
CY2018Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1725000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27493000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18441000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2394000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1544000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-762785000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-731969000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5887000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3976000
CY2019Q1 us-gaap Royalty Expense
RoyaltyExpense
87000
CY2018Q1 us-gaap Royalty Expense
RoyaltyExpense
140000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6238000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7609000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3317000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2903000
CY2018Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.50
CY2018Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10455000
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
220000
CY2018Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
187000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
343000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
81000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
22507000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
49235000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
83767000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
62054000
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.7pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The most significant estimates in the Company&#x2019;s consolidated financial statements relate to the valuation of stock options, and the valuation allowance for deferred tax assets resulting from net operating losses. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> readily apparent from other sources. Actual results could differ from those estimates.</div></div></div></div>
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110167000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98592000

Files In Submission

Name View Source Status
0001171843-19-003220-index-headers.html Edgar Link pending
0001171843-19-003220-index.html Edgar Link pending
0001171843-19-003220.txt Edgar Link pending
0001171843-19-003220-xbrl.zip Edgar Link pending
bcrx-20190331.xml Edgar Link completed
bcrx-20190331.xsd Edgar Link pending
bcrx-20190331_cal.xml Edgar Link unprocessable
bcrx-20190331_def.xml Edgar Link unprocessable
bcrx-20190331_lab.xml Edgar Link unprocessable
bcrx-20190331_pre.xml Edgar Link unprocessable
exh_101.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_050919p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending